BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 22043770)

  • 1. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
    Moungnoi P; Maipang P
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
    Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
    Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methylphenidate on height and weight in Korean children and adolescents with attention-deficit/hyperactivity disorder: a retrospective chart review.
    Kim HW; Kim SO; Shon S; Lee JS; Lee HJ; Choi JH
    J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):448-53. PubMed ID: 25285915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of stimulants on height and weight: a review of the literature.
    Faraone SV; Biederman J; Morley CP; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD.
    Zhang H; Du M; Zhuang S
    Neuropediatrics; 2010 Aug; 41(2):55-9. PubMed ID: 20799150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
    Wilens T; Pelham W; Stein M; Conners CK; Abikoff H; Atkins M; August G; Greenhill L; McBurnett K; Palumbo D; Swanson J; Wolraich M
    J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):424-33. PubMed ID: 12649629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight, Height, and Body Mass Index in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate.
    Díez-Suárez A; Vallejo-Valdivielso M; Marín-Méndez JJ; de Castro-Manglano P; Soutullo CA
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):723-730. PubMed ID: 28817309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of osmotic-release methylphenidate on height and weight in children with attention-deficit hyperactivity disorder (ADHD) following up to four years of treatment.
    Durá-Travé T; Yoldi-Petri ME; Gallinas-Victoriano F; Zardoya-Santos P
    J Child Neurol; 2012 May; 27(5):604-9. PubMed ID: 22190507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of methylphenidate on growth of school age children with attention deficit hyperactivity disorder].
    Zhang HY; Du ML; Zhuang SQ; Liu MN
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):723-7. PubMed ID: 16255846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant treatment over 5 years: effects on growth.
    Charach A; Figueroa M; Chen S; Ickowicz A; Schachar R
    J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):415-21. PubMed ID: 16601646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nutrition and attention deficit hyperactivity disorder: developmental follow-up of the anthropometric variables of a group of patients receiving treatment with osmotic controlled-release methylphenidate].
    Dura-Trave T; Yoldi-Petri ME; Zardoya-Santos P
    Rev Neurol; 2011 Sep; 53(5):257-64. PubMed ID: 21796603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Switching from a short-acting to a long-acting methylphenidate preparation: a multicentre, open study in children with ADHD].
    Heger S; Trott GE; Meusers M; Schulz E; Rothenberger A; Rettig K; Medori R; Schreiner A; Remschmidt H;
    Z Kinder Jugendpsychiatr Psychother; 2006 Jul; 34(4):257-65. PubMed ID: 16927568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
    Spencer TJ; Biederman J; Harding M; O'Donnell D; Faraone SV; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1460-9. PubMed ID: 8936912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population.
    Hodgkins P; Sasané R; Christensen L; Harley C; Liu F
    Curr Med Res Opin; 2011; 27 Suppl 2():53-62. PubMed ID: 21973231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Methylphenidate Treatment on Child Growth in Thai Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Koonrungsesomboon K; Koonrungsesomboon N
    J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):189-197. PubMed ID: 31841645
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder.
    Pliszka SR; Matthews TL; Braslow KJ; Watson MA
    J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):520-526. PubMed ID: 16670648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
    Mulhern RK; Khan RB; Kaplan S; Helton S; Christensen R; Bonner M; Brown R; Xiong X; Wu S; Gururangan S; Reddick WE
    J Clin Oncol; 2004 Dec; 22(23):4795-803. PubMed ID: 15570081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADHD and growth: anthropometric changes in medicated and non-medicated ADHD boys.
    Ptacek R; Kuzelova H; Paclt I; Zukov I; Fischer S
    Med Sci Monit; 2009 Dec; 15(12):CR595-9. PubMed ID: 19946228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.